Zymergen was a synthetic-biology and bio-manufacturing company founded in 2013 in Emeryville, California, that used machine learning and automation to engineer microbes and discover novel bio-based materials and molecules. It went public on NASDAQ in 2021 and was acquired by Ginkgo Bioworks in October 2022; the zymergen.com domain now 301-redirects to Ginkgo Bioworks. It was surfaced as a portfolio company of DCVC, Kindred Ventures, and Obvious Ventures and added to the API Evangelist network for enrichment. Enrichment found no public developer portal, API, documentation, or event surface — the company has no independent API footprint following the acquisition. This profile is retained as a portfolio/history record.
Zymergen is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, Biotechnology, Biomanufacturing, and Materials Science.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/zymergen: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: zymergen
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- url: https://zymergen.com/
status: 301
note: declared website redirects to https://www.ginkgo.bio/2022/10/19/ginkgo-acquires-zymergen — a different registrable
domain (zymergen.com -> ginkgo.bio), possible rename or acquisition (probed 2026-09-03, roadmap#169)
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/zymergen.png
name: Zymergen
description: Zymergen was a synthetic-biology and bio-manufacturing company founded in 2013 in Emeryville, California, that
used machine learning and automation to engineer microbes and discover novel bio-based materials and molecules. It went
public on NASDAQ in 2021 and was acquired by Ginkgo Bioworks in October 2022; the zymergen.com domain now 301-redirects
to Ginkgo Bioworks. It was surfaced as a portfolio company of DCVC, Kindred Ventures, and Obvious Ventures and added to
the API Evangelist network for enrichment. Enrichment found no public developer portal, API, documentation, or event surface
— the company has no independent API footprint following the acquisition. This profile is retained as a portfolio/history
record.
url: https://raw.githubusercontent.com/api-evangelist/zymergen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
- kindred-ventures
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: ginkgo-bioworks
x-acquired-date: '2022-10-19'
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Synthetic Biology
- Biotechnology
- Biomanufacturing
- Materials Science
- Machine-Learning
- Acquired
tags_raw:
- Company
- Synthetic Biology
- Biotechnology
- Bio-manufacturing
- Materials Science
- Machine Learning
- Acquired
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/zymergen-domain-security.yml
- type: Website
url: https://zymergen.com/
- type: Acquisition
url: https://www.ginkgo.bio/2022/10/19/ginkgo-acquires-zymergen/
x-enrichment:
date: '2026-07-21'
status: minimal
artifacts_added: 1
pass: local-v1
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →